| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE | 125 |
| 1 | METHOTREXATE SODIUM | 93 |
| 2 | METHOTREXATE | 83 |
| 3 | OXYCODONE HYDROCHLORIDE | 64 |
| 4 | FLUOROURACIL | 60 |
| 5 | FLUOROURACIL CREAM, 0.5% | 60 |
| 6 | FENTANYL | 59 |
| 7 | OXALIPLATIN | 57 |
| 8 | CAPECITABINE | 49 |
| 9 | FLUDARABINE PHOSPHATE | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | NELARABINE | 11 | 0.0113 |
| 2 | COCAINE HYDROCHLORIDE | 4 | 0.0105 |
| 3 | GLUCARPIDASE | 1 | 0.0028 |
| 4 | CLOFARABINE | 5 | 0.0022 |
| 5 | IDARUBICIN HYDROCHLORIDE | 2 | 0.0017 |
| 6 | ACETAZOLAMIDE SODIUM | 10 | 0.0016 |
| 7 | SILTUXIMAB | 1 | 0.0015 |
| 8 | METHADONE HYDROCHLORIDE | 14 | 0.0013 |
| 9 | FLUDARABINE PHOSPHATE | 48 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 145 |
| 1 | Opioid Agonist [EPC] | 144 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 83 |
| 3 | Corticosteroid [EPC] | 77 |
| 4 | Platinum-based Drug [EPC] | 77 |
| 5 | Alkylating Drug [EPC] | 49 |
| 6 | Atypical Antipsychotic [EPC] | 46 |
| 7 | Benzodiazepine [EPC] | 46 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 40 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Oxazolidinone Antibacterial [EPC] | 21 | 0.0007 |
| 3 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 4 | Opioid Agonist [EPC] | 144 | 0.0005 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 145 | 0.0005 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 10 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 9 | 0.0004 |
| 9 | CD30-directed Immunoconjugate [EPC] | 4 | 0.0004 |